Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

00:31 EDT 31st August 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 28,000+

Friday 29th August 2014

District Court Decision Received In Remodulin Patent Case

SILVER SPRING, Md., Aug. 29, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. District Court for the District of New Jersey has ruled in its favor in the company's case against Sandoz, Inc. regarding United Therapeutics' Remodulin® product.  In his opinion, Judge Peter Sheridan ruled that U.S. Patent No. 6,765,117 is both valid a...

Experimental Ebola drug heals all monkeys in study (Update)

An experimental Ebola drug healed all 18 monkeys infected with the deadly virus in a study, boosting hopes that the treatment might help fight the outbreak raging through West Africa—once more of it can be made.

Revealing novel mode of action for osteoporosis drug

Raloxifene is a US Food and Drug Administration-approved treatment for decreasing fracture risk in osteoporosis. While raloxifene is as effective at reducing fracture risk as other current treatments, this works only partially by suppressing bone los...

FDA Plan To Diversify Clinical Trials Raises Some Concerns

Women's advocacy groups complain that the plan doesn't have "teeth" needed to make a change. The Wall Street Journal: FDA Is Chastised Over Its 'Action Plan' To Diversify Clinical Trial Participation In response to a law passed two years ago, the FDA was directed to assess the extent to which women and minorities are represented in clinical trials and also devise a plan to bolster their participa...

BioCryst: Experimental Ebola drug will be tested on primates within weeks

(Reuters) - BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use against Ebola infections The biotechnology company's stock was...

Amgen's Cholesterol-Lowering Drug Meets Co-Primary Endpoints

Amgen announced that the Phase 3 YUKAWA-2 (StudY of LDL-Cholesterol Reduction Using a Monoclonal PCSK9 Antibody in Japanese Patients With 

An End to Drug Errors?

Read more about An End to Drug Errors?Comments

Accelerate Drug Development with Optimized Content Management

Getting a new drug from the laboratory to the pharmacy takes years of testing, applications and information sharing. One way to shorten the drug development life cycle is to optimize content management.

Seaweed Suppository Delivers HIV Drugs

Medical researchers have devised a new means of tackling HIV and AIDS transmission - a vaginally-inserted suppository which contains the antiretroviral Tenofovir. Developed by a team at Penn State University's College of Agricultural Science, the dru...

CVS Caremark To Present At The Morgan Stanley 2014 Global Healthcare Conference

WOONSOCKET, R.I., Aug. 29, 2014 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) today announced that Larry Merlo, the company's president and chief executive officer, will be making a presentation to investors at the Morgan Stanley 2014 Global Healthcare Conference on September 9, 2014. He is scheduled to present at approximately 8:35 a.m. (EDT). An audio webcast of the presentation will b...

Senesco Closes Enrollment in Its Phase 1b/2a SNS01-T Study

Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTCQB:SNTI) today announced the closing of enrollment in its ongoing Phase 1b/2a open-label, multiple-dose, dose-escalation clinical trial of SNS01-T, a first-in-class modulator of eukaryotic translation initiation factor 5A (eIF5A), in patients with relapsed or refractory multiple myeloma, p...

FDA approves Elelyso for pediatric use in Gaucher disease

The US Food and Drug Administration has approved US pharma giant Pfizer’s Elelyso (taliglucerase alfa) for injection for pediatric patients with Type 1 Gaucher disease.

Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade

Reston, VA (PRWEB) August 29, 2014 The Department of Health and Human Services (HHS), Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), awarded a five-year, single-award, indefinite delivery, indefinite quan...

The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments

DEA’s announcement comes after a recommendation last year concerning the potent combination drug products. Port Washington, New York (PRWEB) August 29, 2014 Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured by medications reports that the Drug Enforcement Administration (DEA) has announced new regulations for all hydr...

Xarelto Indication Expansion Efforts Show That Fewer Could Be More

J&J and Bayer continue quest for acute coronary syndrome claim following three rejections by FDA; this time, Xarelto will be tested on top of only one antiplatelet drug instead of two.

Researchers reveal transmission rate of MERS coronavirus

The MERS coronavirus has caused disease outbreaks across the Arabian Peninsula and spread to Europe several times. The severe pneumonia virus has claimed the lives of several hundred people since its discovery in 2012.

Minomic to reformulate its MIL-38 prostate cancer screening target as a therapy with Catalent

Australian biotech company Minomic International will join forces with Catalent Pharma to develop its MIL-38 antibody drug conjugate as a potential therapy for prostate cancer.

Takeda's 10-year study finds no link between pioglitazone and bladder cancer

Japan’s largest drugmaker Takeda has completed the post-marketing commitment and data submissions to regulators including the US Food and Drug Administration and the European Medicines Agency from a 10-year epidemiology study for pioglitazone-conta...

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

After failing to meet the primary endpoint of its trial of rigosertib (IV), oncology specialist Onconova has informed the investment community that it will be pursuing an indication of the drug in patients where primary hypomethylating agents (HMA) f...

InnoPharma receives FDA approval for generic DACOGEN

InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s DACOGEN.

CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar

Washington, D.C. (PRWEB) August 29, 2014 Today, Gen. Arthur T. Dean, Chairman and CEO of Community Anti-Drug Coalitions of America (CADCA) , the nation’s leading substance abuse prevention organization, issued the following statement in resp...

Pfizer seeks US FDA approval for its new drug

Biospectrum [Read more]

Friday's most followed in U.S. including Big Lots, Amira Nature, Pacific Sunwear, BioCryst, AstraZeneca, J&J, Avago, Veeva, Albemarle

U.S. shares rose amid increasing bets that global central banks will support economic growth. The S&P 500 (INDEXSP:.INX) rose 0.2 percent at 11:24 a.m. in New York. The 30-company Dow Jones Industrial Average (INDEXDJX:.DJI) was little changed, a...

First Edition: August 29, 2014

Today's early morning highlights from the major news organizations, including reports about the Obama administration and Pennsylvania reaching an agreement to expand Medicaid in that state. Kaiser Health News: Beware Of Higher Charges If You Go To An Out-Of-Network Emergency Room Kaiser Health News' consumer columnist Michelle Andrews reports: "When you need emergency care, chances are you aren&rs...

Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019

DALLAS, August 29, 2014 /PRNewswire/ -- According to the new research report "Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global Forecast to 2019" published by MarketsandMarkets, the global Oligonucl...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks